1. Home
  2. ADT vs AMRX Comparison

ADT vs AMRX Comparison

Compare ADT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADT Inc.

ADT

ADT Inc.

HOLD

Current Price

$6.42

Market Cap

4.8B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.03

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADT
AMRX
Founded
1874
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.0B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ADT
AMRX
Price
$6.42
$17.03
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.75
$15.60
AVG Volume (30 Days)
9.3M
2.2M
Earning Date
04-30-2026
05-01-2026
Dividend Yield
3.07%
N/A
EPS Growth
29.63
157.89
EPS
N/A
0.19
Revenue
$5,128,607,000.00
N/A
Revenue This Year
$1.90
$4.48
Revenue Next Year
$2.91
$7.13
P/E Ratio
N/A
$90.68
Revenue Growth
4.70
N/A
52 Week Low
$6.24
$7.67
52 Week High
$8.94
$17.86

Technical Indicators

Market Signals
Indicator
ADT
AMRX
Relative Strength Index (RSI) 39.07 76.83
Support Level $6.27 $12.46
Resistance Level $6.79 N/A
Average True Range (ATR) 0.16 0.65
MACD -0.02 0.11
Stochastic Oscillator 29.55 79.36

Price Performance

Historical Comparison
ADT
AMRX

About ADT ADT Inc.

ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: